pubmed-article:8167208 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8167208 | lifeskim:mentions | umls-concept:C0058698 | lld:lifeskim |
pubmed-article:8167208 | lifeskim:mentions | umls-concept:C0011570 | lld:lifeskim |
pubmed-article:8167208 | lifeskim:mentions | umls-concept:C0444706 | lld:lifeskim |
pubmed-article:8167208 | lifeskim:mentions | umls-concept:C0040399 | lld:lifeskim |
pubmed-article:8167208 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:8167208 | pubmed:dateCreated | 1994-6-2 | lld:pubmed |
pubmed-article:8167208 | pubmed:abstractText | Psychobiological theories of mood disorders have been concerned mainly with noradrenaline and serotonin. There exists, however, a recent upsurge of interest in dopamine. We have used single photon emission computed tomography and 123I-iodobenzamide, a high-affinity ligand for D2 receptors, to study these receptors in depression. Subjects were 21 (unipolar) depressed inpatients and 11 normal controls. The mean basal ganglia/cerebellum uptake ratio was 1.94 (+/- 0.27) in the depressed patients versus 1.74 (+/- 0.17) in the controls. This difference was statistically significant (Mann-Whitney U test, p = 0.025). These data could indicate an increase of D2 receptor density in depression. | lld:pubmed |
pubmed-article:8167208 | pubmed:language | eng | lld:pubmed |
pubmed-article:8167208 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8167208 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8167208 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8167208 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8167208 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8167208 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8167208 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8167208 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8167208 | pubmed:month | Jan | lld:pubmed |
pubmed-article:8167208 | pubmed:issn | 0006-3223 | lld:pubmed |
pubmed-article:8167208 | pubmed:author | pubmed-author:BossuytAA | lld:pubmed |
pubmed-article:8167208 | pubmed:author | pubmed-author:D'haenenH AHA | lld:pubmed |
pubmed-article:8167208 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8167208 | pubmed:day | 15 | lld:pubmed |
pubmed-article:8167208 | pubmed:volume | 35 | lld:pubmed |
pubmed-article:8167208 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8167208 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8167208 | pubmed:pagination | 128-32 | lld:pubmed |
pubmed-article:8167208 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:8167208 | pubmed:meshHeading | pubmed-meshheading:8167208-... | lld:pubmed |
pubmed-article:8167208 | pubmed:meshHeading | pubmed-meshheading:8167208-... | lld:pubmed |
pubmed-article:8167208 | pubmed:meshHeading | pubmed-meshheading:8167208-... | lld:pubmed |
pubmed-article:8167208 | pubmed:meshHeading | pubmed-meshheading:8167208-... | lld:pubmed |
pubmed-article:8167208 | pubmed:meshHeading | pubmed-meshheading:8167208-... | lld:pubmed |
pubmed-article:8167208 | pubmed:meshHeading | pubmed-meshheading:8167208-... | lld:pubmed |
pubmed-article:8167208 | pubmed:meshHeading | pubmed-meshheading:8167208-... | lld:pubmed |
pubmed-article:8167208 | pubmed:meshHeading | pubmed-meshheading:8167208-... | lld:pubmed |
pubmed-article:8167208 | pubmed:meshHeading | pubmed-meshheading:8167208-... | lld:pubmed |
pubmed-article:8167208 | pubmed:meshHeading | pubmed-meshheading:8167208-... | lld:pubmed |
pubmed-article:8167208 | pubmed:meshHeading | pubmed-meshheading:8167208-... | lld:pubmed |
pubmed-article:8167208 | pubmed:meshHeading | pubmed-meshheading:8167208-... | lld:pubmed |
pubmed-article:8167208 | pubmed:meshHeading | pubmed-meshheading:8167208-... | lld:pubmed |
pubmed-article:8167208 | pubmed:meshHeading | pubmed-meshheading:8167208-... | lld:pubmed |
pubmed-article:8167208 | pubmed:meshHeading | pubmed-meshheading:8167208-... | lld:pubmed |
pubmed-article:8167208 | pubmed:meshHeading | pubmed-meshheading:8167208-... | lld:pubmed |
pubmed-article:8167208 | pubmed:year | 1994 | lld:pubmed |
pubmed-article:8167208 | pubmed:articleTitle | Dopamine D2 receptors in depression measured with single photon emission computed tomography. | lld:pubmed |
pubmed-article:8167208 | pubmed:affiliation | Psychiatric Department, Academic Hospital, Free University of Brussels, Belgium. | lld:pubmed |
pubmed-article:8167208 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8167208 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8167208 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8167208 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8167208 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8167208 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8167208 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8167208 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8167208 | lld:pubmed |